Holen Sie sich die Stockscreener-App
2.56
6.23%
-0.17
Schlusskurs vom Vortag:
$2.73
Offen:
$2.555
24-Stunden-Volumen:
965.09K
Relative Volume:
0.36
Marktkapitalisierung:
$60.38M
Einnahmen:
$155.00K
Nettoeinkommen (Verlust:
$-30.01M
KGV:
-1.5329
EPS:
-1.67
Netto-Cashflow:
$-11.98M
1W Leistung:
-5.54%
1M Leistung:
+22.49%
6M Leistung:
-74.80%
1J Leistung:
-67.64%
1-Tages-Spanne:
$2.45
$2.64
1-Wochen-Bereich:
$2.45
$3.244
52-Wochen-Spanne:
$1.89
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Firmenname
Inmune Bio Inc
Sektor
Branche
Telefon
(858) 964-3720
Adresse
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Vergleichen Sie INMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
2.56 | 74.37M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-01 | Herabstufung | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-10-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-05-24 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-21 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-22 | Bestätigt | Maxim Group | Buy |
| 2020-09-01 | Eingeleitet | BTIG Research | Buy |
| 2020-07-15 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
What are the technical indicators suggesting about INmune Bio Inc.Build wealth with long-term growth strategies - jammulinksnews.com
How does INmune Bio Inc. generate profit in a changing economyConsistent triple-digit returns - jammulinksnews.com
What institutional investors are buying INmune Bio Inc. stockBuild wealth faster with disciplined trading - jammulinksnews.com
Is INmune Bio Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com
What analysts say about INmune Bio Inc. stockTremendous gains - jammulinksnews.com
Is INmune Bio Inc. a growth stock or a value stockBuild a diversified portfolio for steady growth - jammulinksnews.com
What are analysts’ price targets for INmune Bio Inc. in the next 12 monthsExplosive wealth accumulation - jammulinksnews.com
How does INmune Bio Inc. compare to its industry peersGet real-time alerts on high-potential stocks - jammulinksnews.com
What makes INmune Bio Inc. stock price move sharplyUnlock powerful trading alerts for success - jammulinksnews.com
What is INmune Bio Inc. company’s growth strategyAccelerated wealth building - jammulinksnews.com
What drives INmune Bio Inc. stock priceDouble-digit growth - jammulinksnews.com
Is it the right time to buy INmune Bio Inc. stockFinancial News Planner Backed By Experts - jammulinksnews.com
INmune Bio Inc. May Be Forming Higher Low — Chartwatchers AlertReal Trader Watchlist of Hot Stocks Released - metal.it
Price Channel Expanding on INmune Bio Inc.’s ChartOversold Bounce Stock Play Ideas Gain Attention - metal.it
Inmune Bio Inc. shares fall 1.83% after-hours as the company prepares to report Q2 2025 financial results. - AInvest
INmune Bio Inc. to Host Conference Call on August 7, 2025 for Q2 Results and Corporate Update - Quiver Quantitative
INmune Bio Announces Q1 Earnings Call on August 7th, 2025 at 4:30 PM EDT. - AInvest
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th - The Manila Times
INmune Bio to Present Q2 2025 Financial Results and Key Clinical-Stage Updates on August 7 - Stock Titan
When is INmune Bio Inc. stock expected to show significant growthReal Time Guidance For 2025 - jammulinksnews.com
Inmune Bio shares fall 2.53% premarket after announcing a video detailing MINDFuL trial findings. - AInvest
Inmune Bio Inc. shares fall 4.75% after-hours following the release of a video detailing the MINDFuL trial. - AInvest
INmune Bio Releases Video on Alzheimer’s Trial Results - TipRanks
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference - The Manila Times
INmune Bio To Share New Alzheimer's Trial Results On YouTube After Major Conference Reveal - 富途牛牛
INmune Bio to Publish Video on MINDFuL Trial Findings for XPro™ Treatment at Alzheimer's Association International Conference. - AInvest
Breakthrough in Alzheimer's Treatment: Phase 2 Trial Reveals XPro Drug's Impact on Cognitive Decline - Stock Titan
How INmune Bio Inc. stock performs during market volatilityROI Driven Equity Selection With Safety Emphasized - metal.it
Trend Reversal Possible in INmune Bio Inc. Charts IndicateSwing Trade Entry With Volume Triggers Released - metal.it
Is INmune Bio Inc. Stock a Good Fit for Conservative InvestorsDaily Volume Spike Trading Signals Detected - metal.it
Alzheimer’s Breakthrough: INmune Bio’s XPro Trial Shows Promise in Subpopulation - StocksToTrade
INmune Bio Stock Soars 19.56% on Clinical Trial Success - AInvest
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge? - Benzinga
How many analysts rate INmune Bio Inc. as a “Buy”Achieve breakthrough profits with expert advice - jammulinksnews.com
New Product Launches: Will They Boost INmune Bio Inc. Stock in 2025Best Stocks for Capital Safety - metal.it
Inmune Bio Reveals Promising XPro™ Trial Results - The Globe and Mail
Why INmune Bio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - metal.it
Is INmune Bio Inc. a good long term investmentOutstanding capital growth - PrintWeekIndia
INmune Bio Shares Plunge After Alzheimer's Trial Misses Target - Finimize
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at - GuruFocus
INmune Bio Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - PrintWeekIndia
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):